Protective effect of apocynin against gentamicin-induced nephrotoxicity in rats

R S Abdelrahman1

  • 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

Insights

Apocynin (APO) protects against gentamicin (GNT)-induced kidney damage by reducing oxidative stress and inflammation. This study shows APO can be a potential therapeutic agent to mitigate GNT nephrotoxicity.

Area of Science:

  • Pharmacology
  • Toxicology
  • Nephrology

Background:

  • Gentamicin (GNT) is a vital antibiotic for serious infections.
  • Nephrotoxicity is a significant limitation of GNT therapy.
  • Apocynin (APO) is investigated for its potential protective effects.

Purpose of the Study:

  • To evaluate the protective effect of apocynin (APO) against gentamicin (GNT)-induced nephrotoxicity in a rat model.
  • To elucidate the mechanisms underlying APO's renoprotective properties.

Main Methods:

  • Rats were divided into control, GNT-induced nephrotoxicity, and GNT + APO groups.
  • Biochemical markers (creatinine, BUN, LDH, albumin), urine analysis, and kidney tissue assessments were performed.
  • Levels of oxidative stress markers (MDA, NO) and apoptosis markers (CD95) were measured.

Main Results:

  • GNT significantly increased kidney weight, urine volume, serum creatinine, BUN, LDH, and renal oxidative/apoptotic markers.
  • GNT significantly decreased body weight, creatinine clearance, and renal antioxidant enzyme activities (SOD, glutathione).
  • APO treatment significantly ameliorated GNT-induced kidney injury, improving biochemical parameters, reducing oxidative stress and apoptosis, and enhancing antioxidant capacity.

Conclusions:

  • Apocynin exhibits significant anti-inflammatory, antiapoptotic, and antioxidant effects.
  • APO effectively ameliorates gentamicin-induced nephrotoxicity in rats.
  • APO demonstrates potential as a therapeutic agent to prevent or treat GNT-induced kidney damage.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
434
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
305
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
289
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
321